TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value ($000): $435,875 (100.0% shares, 0.0% debt)

Holdings (8)

— ODONATE THERAPEUTICS INC 45.4%

Value ($000) $197,785 Shares 14,047,250 Est. Cost $24.20 Unrealized —

HRTX HERON THERAPEUTICS INC 34.6%

Value ($000) $150,933 Shares 5,818,541 Est. Cost $14.10 Unrealized +95.0%

RCKT ROCKET PHARMACEUTICALS INC 10.1%

Value ($000) $43,948 Shares 2,965,485 Est. Cost $16.31 Unrealized +1.8%

— LA JOLLA PHARMACEUTICAL CO 8.4%

Value ($000) $36,578 Shares 3,878,893 Est. Cost $18.53 Unrealized —

PBYI PUMA BIOTECHNOLOGY INC 1.2%

Value ($000) $5,035 Shares 247,400 Est. Cost $30.01 Unrealized 0.0%

— OPHTHOTECH CORP 0.2%

Value ($000) $720 Shares 600,000 Est. Cost $1.20 Unrealized —

PRTA PROTHENA CORP PLC 0.1%

Value ($000) $490 Shares 47,610 Est. Cost $11.89 Unrealized 0.0%

EQ EQUILLIUM INC 0.1%

Value ($000) $386 Shares 47,343 Est. Cost $13.90 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ODONATE THERAPEUTICS INC	14,047,250	$197,785	45.4%	$24.20	—	COM	676079106
HRTX	HERON THERAPEUTICS INC	5,818,541	$150,933	34.6%	$14.10	+95.0%	COM	427746102
RCKT	ROCKET PHARMACEUTICALS INC	2,965,485	$43,948	10.1%	$16.31	+1.8%	COM	77313F106
—	LA JOLLA PHARMACEUTICAL CO	3,878,893	$36,578	8.4%	$18.53	—	COM	503459604
PBYI	PUMA BIOTECHNOLOGY INC	247,400	$5,035	1.2%	$30.01	0.0%	COM	74587V107
—	OPHTHOTECH CORP	600,000	$720	0.2%	$1.20	—	COM	683745103
PRTA	PROTHENA CORP PLC	47,610	$490	0.1%	$11.89	0.0%	SHS	G72800108
EQ	EQUILLIUM INC	47,343	$386	0.1%	$13.90	0.0%	COM	29446K106